Halliburton Buys Baker, Actavis Snares Allergan & Stanton's Big Deal
Halliburton announced it will buy fellow oil services giant Baker Hughes this week for about $35 billion in cash and stock. Halliburton said it would divest businesses that generate $7.5 billion in sales to satisfy regulators and pay Baker Hughes $3.5 billion if the deal is rejected. Meanwhile, Botox-maker Allergan agreed to be bought by Actavis this week for $66 billion, overcoming a hostile bid by billionaire investor William Ackman and Valeant Pharmaceuticals. The offer values Allergan at $219 per share and is $6 billion more than Valeant’s last offer. Finally, Giancarlo Stanton agreed to a record breaking contract worth $325 million over 13 years with Major League Baseball's Miami Marlins. The two time all-star outfielder led the National League with 37 home runs last season.
